different types of glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Receptor Agonists | New
Description
It results from the metabolic consequences due to a lack of insulin secretion or impaired insulin activity in diabetes leading to dysregulated pathophysiologic pathways resulting in excessive ketone body formation
Method The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched from the establishment of the database to December 24, 2022
For external use only
Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns
How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.
